Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$31.84 - $50.88 $162,224 - $259,233
-5,095 Closed
0 $0
Q2 2019

Aug 16, 2019

SELL
$42.0 - $59.29 $37,968 - $53,598
-904 Reduced 15.07%
5,095 $262,000
Q1 2019

May 13, 2019

SELL
$40.82 - $62.45 $299,292 - $457,883
-7,332 Reduced 55.0%
5,999 $344,000
Q4 2018

Feb 13, 2019

BUY
$39.11 - $75.15 $40,869 - $78,531
1,045 Added 8.51%
13,331 $559,000
Q3 2018

Nov 13, 2018

BUY
$65.0 - $82.15 $535,275 - $676,505
8,235 Added 203.28%
12,286 $928,000
Q2 2018

Aug 10, 2018

BUY
$27.2 - $74.35 $110,187 - $301,191
4,051 New
4,051 $291,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $415M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.